Suche
Lesesoftware
Specials
Info / Kontakt
The Pancreas - An Integrated Textbook of Basic Science, Medicine, and Surgery
von: Hans G. Beger, Andrew L. Warshaw, Ralph H. Hruban, Markus W. Buchler, Markus M. Lerch, John P. Neoptolemos, Tooru Shimosegawa, David C. Whitcomb
Wiley-Blackwell, 2018
ISBN: 9781119188407 , 1216 Seiten
3. Auflage
Format: PDF
Kopierschutz: DRM
Preis: 404,99 EUR
eBook anfordern
Title Page
3
Copyright Page
4
Contents
5
Contributors
15
Preface
31
Abbreviations
32
About the Companion Website
44
Section 1 Anatomy of the Pancreas
45
Chapter 1 Development of the Pancreas and Related Structures
47
Anatomy of the Pancreas
47
Organogenesis in the Region of the Pancreas
47
Early Pancreatic Development
48
Differentiation of Pancreas Cell Types
49
Transcriptional Mechanisms Underlying Pancreatic Cell Fate Decision
50
Development and Disease
50
Acknowledgment
51
References
51
Chapter 2 Anatomy, Histology, and Fine Structure of the Pancreas
54
Introduction
54
Gross Anatomy
54
Histology and Ultrastructure
57
Endocrine Pancreas
64
Acknowledgments
66
References
67
Chapter 3 Congenital and Inherited Anomalies of the Pancreas
68
Introduction
68
Primary Malformations
68
Isolated Congenital Disorders of Pancreatic Endocrine Function
75
Other Hereditary Disorders with Variable Pancreatic Involvement and Metabolic Diseases Affecting the Pancreas
76
Inherited Metabolic Disorders Affecting the Pancreas
77
References
79
Section 2 Physiology and Pathophysiology of Pancreatic Functions
85
Chapter 4 Physiology of Acinar Cell Secretion
87
Introduction
87
Composition of Pancreatic Acinar Juice
87
Acinar Fluid and Enzyme Secretion
88
Ca2+ Signaling
89
Organelles Important for Ca2+ Homeostasis
90
Mechanisms of Ca2+ Signal Generation
92
Ca2+ Entry and Exit
94
Ca2+-Mediated Control of Enzyme Secretion
95
Ca2+-Mediated Control of Fluid Secretion
96
Dangers of Ca2+ Signaling
96
References
97
Chapter 5 Physiology of Duct Cell Secretion
100
Introduction
100
Sequential Secretion by Acinar and Duct Cells
100
Regulation of Ductal Secretion
102
The Ca2+ and cAMP Pathways Synergize to Activate Ductal Secretion
104
Ductal Secretion-Associated Pancreatic Diseases
104
Acknowledgment
104
References
104
Chapter 6 Pathophysiology of Experimental Pancreatitis
107
Introduction
107
Models of Acute Pancreatitis
107
Phases of Acute Pancreatitis
108
Early Intra-Acinar Events in Acute Pancreatitis
108
Conclusion
116
References
116
Chapter 7 Physiology and Pathophysiology of Function of Sphincter of Oddi
119
Introduction
119
Anatomy and Morphology
119
Innervation
120
Physiology
120
Motility of the Sphincter of Oddi
121
Sphincter of Oddi Motility Studies in Animals
121
Sphincter of Oddi Motility in Humans
122
Pathophysiology of the Sphincter of Oddi Dysfunction (SOD)
123
Conclusion
125
References
125
Chapter 8 Neurohormonal and Hormonal Control of Pancreatic Secretion
128
Introduction
128
Stimulation of Pancreatic Secretion
128
Inhibition of Pancreatic Secretion
132
Feedback Regulation of Pancreatic Secretion
133
Conclusion
134
References
134
Chapter 9 Regulation of Pancreatic Protein Synthesis and Growth
139
Introduction
139
Regulation of Protein Synthesis
139
Regulation of Pancreatic Growth
142
References
145
Chapter 10 Fibrogenesis in the Pancreas: The Role of Stellate Cells
150
Introduction
150
Pancreatic Stellate Sells (PSC)
150
Acute Pancreatitis
153
Chronic Pancreatitis
153
Pancreatic Cancer
155
Conclusion
156
References
156
Chapter 11 Fibrogenesis of the Pancreas: The Role of Macrophages
161
Introduction
161
Macrophages
161
Origin and Characteristics of Pancreatic Macrophages
162
Role of Macrophages in Chronic Pancreatitis-Associated Fibrosis
163
Role of Macrophages in Pancreatic Cancer-Associated Fibrosis
164
Conclusion
164
References
165
Chapter 12 Insulo–Acinar Relationship
167
Introduction
167
Structural Relationships Between Pancreatic Islets and Exocrine Pancreas
167
Insulo-Acinar Portal System
168
Regulation of Pancreatic Exocrine Secretion by Islet Hormones
168
Pancreatic Exocrine Function and Diabetes Mellitus
171
References
172
Section 3 Acute Pancreatitis
177
Chapter 13 Epidemiology and Etiology of Alcohol?Induced Pancreatitis
179
Introduction
179
Epidemiology
179
Pathogenesis
179
Summary
186
Acknowledgment
186
References
186
Chapter 14 Epidemiology and Etiology of Acute Biliary Pancreatitis
190
Introduction
190
Etiology of Gallstone Pancreatitis
190
Epidemiology of Biliary Acute Pancreatitis
194
References
197
Chapter 15 Genetic Factors in Acute Pancreatitis
202
Introduction
202
Genetic Susceptibility Factors
202
Multiple Genetic Defects and Susceptibility
205
Progression to Chronic Pancreatitis
206
Future Directions
206
References
207
Chapter 16 The Role of the Intestine and Mesenteric Lymph in the Development of Systemic Inflammation and MODS in Severe Acute Pancreatitis
210
Introduction
210
Role of the Intestine and Mesenteric Lymph in Multiple Organ Dysfunction Syndrome
210
Role of the Intestine in Severe Acute Pancreatitis
211
Altered Gut–Lymph Composition in Acute Pancreatitis
212
Gut–Lymph Toxicity in Acute Pancreatitis
213
Translating the Gut–Lymph Concept to Clinical Treatments for Acute Pancreatitis
213
Conclusion
214
References
214
Chapter 17 The Role of Neurogenic Inflammation in Pancreatitis
217
References
219
Chapter 18 Molecular, Biochemical, and Metabolic Abnormalities in Acute Pancreatitis
222
Introduction
222
Molecular and Biochemical Abnormalities
222
Metabolic and Systemic Abnormalities
225
Electrocardiographic Abnormalities in Acute Pancreatitis
229
References
231
Chapter 19 Histopathology of Acute Pancreatitis
237
Introduction
237
Definition
237
Histopathologic Patterns of Tissue Necrosis
237
Acute Pancreatitis with Type 1 Necrosis Pattern
237
Acute Pancreatitis with Type 2 Necrosis Pattern
240
Acute Pancreatitis with Type 3 Necrosis Pattern
240
Histopathology Related to Etiologic Factors and Pathophysiologic Mechanisms
240
Unsolved Questions
241
References
241
Chapter 20 Clinical Classification Systems of Acute Pancreatitis
243
Introduction
243
Reasons for Classifying the Severity of Acute Pancreatitis
243
New Classification Systems
243
Validation and Comparison of Classification Systems
244
Future of Classification Systems
244
Conclusions
246
References
246
Chapter 21 Clinical Assessment and Biochemical Markers to Objectify Severity and Prognosis
248
Introduction
248
Historical Perspectives: Approaches to Severity Assessment
248
Dynamics of Organ Failure
249
Multiparameter Scoring Systems
249
Laboratory Variables
251
Overview
253
References
253
Chapter 22 Acute Pancreatitis Associated With Congenital Anomalies
257
Introduction
257
Pancreas Divisum
257
Anomalous Pancreaticobiliary Ductal Union
258
Choledochal Cyst/Choledochocele
258
Annular Pancreas
259
Ectopic Pancreatic Tissue
259
Enteric Duplication Cysts
259
Conclusions
260
References
260
Chapter 23 Acute Pancreatitis in Children
263
Introduction
263
Incidence
263
Etiology
263
Pathophysiology
264
Investigations
264
Diagnosis
266
Imaging
268
Management
269
Outcomes
270
Acute Recurrent Pancreatitis
270
References
271
Chapter 24 Acute Pancreatitis Associated With Metabolic Disorders, Infectious Diseases, or Drugs
274
Introduction
274
Metabolic Diseases
274
Infectious Diseases
275
Drug-Related Diseases
276
References
279
Chapter 25 Radiologic Diagnosis and Staging of Severe Acute Pancreatitis
282
Introduction
282
Classification of Acute Pancreatitis
282
Radiographic Diagnosis of Severe Acute Pancreatitis
285
Diagnosis of Local Complications of Acute Pancreatitis
286
Radiologic Staging of Severe Acute Pancreatitis
288
Limitations and Pitfalls of Radiological Diagnosis of Acute Pancreatitis
289
References
292
Clinical Course and Medical Treatment of Acute Pancreatitis
295
Chapter 26 Conservative Therapy of Acute Pancreatitis: Volume Substitution and Enteral and Parenteral Nutrition
295
Introduction
295
Fluid Resuscitation
295
Enteral and Parenteral Nutrition
298
Conclusions
299
References
299
Chapter 27 ICU Treatment of Severe Acute Pancreatitis
302
Introduction
302
Pre?ICU Management
302
Special Considerations
304
Indications for ICU Admission
304
ICU Treatment of Severe Acute Pancreatitis
305
Early ICU Management (0–48 Hours from Onset of Pain)
305
Management of Metabolic Derangements
306
Late ICU Management (>48?Hours After the Onset of Pain)
306
Management of Infectious Risks
307
Transition Planning
307
References
307
Chapter 28 Use of Antibiotics in Severe Acute Pancreatitis: Indications and Limitations
309
Introduction
309
Infectious Complications
309
Spectrum of Bacteria
310
Rationales for Antibiotics in Acute Pancreatitis
310
Clinical Studies with Antibiotics
311
Indications for Antibiotic Treatment
311
Limitations of Antibiotic Treatment
313
References
313
Interventional and Surgical Management of Acute Pancreatitis
315
Chapter 29 Indications for Interventional and Surgical Treatment of Necrotizing Pancreatitis
315
Introduction
315
Interventions for Pancreatic Necrosis: Historical Perspective
315
Indications and Timing of Intervention
316
Pancreatic Necrosis with Infection
316
Symptomatic Pancreatic Necrosis/Walled-Off Necrosis
316
Surgical and Interventional Procedures
317
Surgical Debridement
317
Percutaneous Catheter Drainage
318
Direct Endoscopic Necrosectomy
319
References
319
Chapter 30 Management of Infected Pancreatic Necroses: An Endoscopic Approach
321
Pancreatic Necrosis
321
Mechanical Intervention
321
Transmural Drainage
322
Results of Endoscopic Therapy of Pancreatic Necrosis
324
Adverse Events of Endoscopic Therapy of Pancreatic Necrosis
324
References
325
Chapter 31 Minimally Invasive Debridement and Lavage of Necrotizing Pancreatitis
327
Introduction
327
Technique
327
Techniques for Complex Collections
329
Early Complications
330
Postoperative Course
330
Outcome
331
References
331
Chapter 32 Open Surgical Debridement in Necrotizing Pancreatitis
333
Introduction
333
General Technique of Open Surgical Debridement
333
Continuous Closed Lavage
334
Debridement and Open Packing/Staged Laparotomy
334
Debridement and Closed Packing
336
Open Cystogastrostomy for Walled?Off Pancreatic Necrosis
337
Conclusion
337
References
338
Chapter 33 Endoscopic Treatment of Biliary Acute Pancreatitis
340
Pathogenesis of Acute Biliary Pancreatitis
340
Diagnosis
340
Indication of Endoscopic Treatment
340
Techniques
341
Outcomes and Timing of Endoscopic Interventions
341
Cholecystectomy After Endoscopic Treatment
343
References
343
Chapter 34 Strategies for the Treatment of Pancreatic Pseudocysts and Walled-Off Necrosis After Acute Pancreatitis: Interventional Endoscopic Approaches
345
Introduction
345
Indications for Endoscopic Treatment
345
Endoscopic Drainage vs. Necrosectomy: Choosing the Right Patient
345
Preventing Recurrence by Treating Disconnected Duct Syndrome
346
References
346
Chapter 35 Strategies for the Treatment of Pancreatic Pseudocysts and Walled-Off Necrosis After Acute Pancreatitis: Surgical Treatment
349
Introduction
349
Definition of Pancreatic Pseudocyst and Walled?Off Necrosis
349
Indications for Surgical Intervention
350
Timing of Interventions and Optimal Interventional Strategy for Walled?Off Necrosis
350
Surgical Intervention for PPC
351
References
352
Chapter 36 Management of Fluid Collection in Acute Pancreatitis
355
Introduction
355
Definitions
355
Imaging of Acute Fluid Collections
356
Conservative Treatment of Pancreatitis and Pancreatic Fluid Collections
356
Conclusion
358
References
358
Chapter 37 Management of Pancreatic Fistula in Acute Pancreatitis
360
Introduction
360
Pathogenesis and Classification
360
Diagnosis
362
Management of External Fistulas
362
Management of Internal Fistulas
364
Conclusions
364
References
365
Long-Term Outcome After Treatment of Acute Pancreatitis
367
Chapter 38 Long-Term Outcome After Acute Pancreatitis
367
Introduction
367
Risk Factors
368
Endocrine Pancreatic Dysfunction
368
Exocrine Dysfunction
368
Recurrent Pancreatitis and Chronic Pancreatitis
369
Quality of Life and Pain
370
Incisional Hernia
371
Pancreatic Cancer and Pancreas?Related Death
371
Imaging Findings
371
Postpancreatitis Care and Follow?Up Visits
371
Conclusions
372
References
372
Section 4 Chronic Pancreatitis
375
Chapter 39 Molecular Understanding of Chronic Pancreatitis
377
Introduction
377
Risk Factors in Chronic Pancreatitis
377
Sentinel Acute Pancreatic Event Model
378
Epigenetics as a Modifying Factor in Chronic Pancreatitis
380
Environmental Exposures as Modifying Factors in Chronic Pancreatitis
380
Genetic Influences in Chronic Pancreatitis
381
Inflammatory Response in Chronic Pancreatitis
381
Fibrogenesis in Chronic Pancreatitis
382
Conclusions
382
References
383
Chapter 40 Epidemiology and Pathophysiology of Alcoholic Chronic Pancreatitis
386
Introduction
386
Epidemiology of Alcoholic Chronic Pancreatitis
386
Pathophysiology
387
Co-Predisposing Factors for the Development of Alcoholic Chronic Pancreatitis
389
References
390
Chapter 41 Pain Mechanisms in Chronic Pancreatitis
393
Introduction
393
Extrapancreatic Pain
393
Pancreatic Pain
394
Neural Remodeling
394
Conclusions
396
References
397
Chapter 42 Natural History of Recurrent Acute and Chronic Pancreatitis
399
Introduction
399
Natural History After First Attack of Acute Pancreatitis
399
Natural History of Chronic Pancreatitis
403
Conclusion
406
Chapter 43 Chronic Pancreatitis with Inflammatory Mass of the Pancreatic Head
409
Introduction
409
Incidence
409
Symptoms, Pathophysiology, and Clinical Problems
409
Clinical Workup and Differential Diagnosis
410
Treatment
411
Conclusions
412
References
412
Chapter 44 Early Chronic Pancreatitis
415
Introduction
415
Diagnosis of Early Chronic Pancreatitis
415
References
416
Chapter 45 Hereditary Chronic Pancreatitis: Molecular Pattern, Clinical Consequences, and Management Principles
418
Clinical and Genetic Definitions
418
Epidemiology
418
Clinical Presentation
419
Management
420
Molecular Genetics
421
Genetic Testing and Counseling
423
References
424
Chapter 46 Epidemiology and Pathophysiology of Tropical Chronic Pancreatitis
428
Introduction
428
Pathophysiology
429
Natural History of the Disease
431
Conclusion
431
References
431
Chapter 47 Cystic Fibrosis (CFTR)-Associated Pancreatic Disease
435
Introduction
435
Pathophysiology—Genotype and Phenotype Correlations
435
Clinical Manifestations
436
Diagnosis
437
Therapy
437
References
438
Chapter 48 Clinical and Laboratory Diagnosis of Chronic Pancreatitis
441
Introduction
441
Clinical Presentation
441
Etiology
442
Pain
442
Malabsorption and Weight Loss
443
Endocrine Insufficiency
443
Jaundice
444
Laboratory Diagnosis
444
Conclusion
446
References
446
Chapter 49 Evidence of Contrast-Enhanced CT and MRI/MRCP
450
Introduction
450
Diagnosis of Chronic Pancreatitis
451
Differential Diagnosis of Mass-Forming Chronic Pancreatitis and Pancreatic Cancer
455
CT and MRI for Autoimmune Pancreatitis
455
CT and MRI for Groove Pancreatitis
456
Complications of Chronic Pancreatitis
457
References
459
Chapter 50 Chronic Pancreatitis: Risk Factors in Cancer
461
Introduction
461
Descriptive Findings
461
Measuring the Strength of the Pancreatitis–Pancreatic Cancer Association
461
Discussion
462
References
464
Conservative Treatment of Chronic Pancreatitis
465
Chapter 51 Pain Management in Chronic Pancreatitis
465
Introduction
465
Neuropathologic Theory
465
The Plumbing Theory
465
Pain Measurement
466
Treatment Options for Patients with Chronic Pancreatitis
467
Timing
468
Conclusions
468
References
468
Chapter 52 Medical Treatment of Chronic Pancreatitis: Pancreatic Digestive Enzymes: Lipases, Proteases:
470
Introduction
470
Management of Exocrine Pancreatic Insufficiency
470
Emerging Therapies
472
References
472
Chapter 53 Nutritional Support of Chronic Pancreatitis
473
Introduction
473
Undernutrition
473
Nutrient Deficiency
473
Micronutrient Supplementation
474
Osteoporosis and Bone Health
474
Dietary Intervention
474
Enteral and Parenteral Nutrition
475
Combined Pancreatic Exocrine and Endocrine Deficiency
475
Structured Nutritional Assessment
475
References
476
Chapter 54 Medical Therapy for Chronic Pancreatitis: Antioxidants
479
Introduction
479
Pain and Oxidative Stress
479
Clinical Studies of Antioxidants for Pain
480
Conclusions
481
References
481
Strategies for Endoscopic and Surgical Treatment of Chronic Pancreatitis
483
Chapter 55 Evidence of Endoscopic and Interventional Treatment of Chronic Pancreatitis and Pseudocysts
483
Indications for Interventional Endoscopic or Surgical Therapy
483
Treatment of Pancreatic Cysts
484
Therapy of Pancreatic Duct Stenoses and Ductal Stones
486
Endoscopic Treatment of Bile Duct Obstruction
488
References
489
Chapter 56 Indications and Goals of Surgical Treatment
493
Introduction
493
Surgical Drainage of the Pancreatic Duct
493
Surgical Resection of the Pancreas
494
Surgical Management of Biliary Obstruction
495
References
496
Chapter 57 Pancreatic Duct Drainage Procedure
497
Introduction
497
Indication for Surgery
497
Drainage Procedures
498
Conclusion
499
References
499
Chapter 58 Duodenum-Preserving Pancreatic Head Resection
502
Introduction
502
Are Duct Stenting and Endoscopic Interventions an Alternative to Surgery?
502
Who Benefits from Surgical Treatment?
503
Kausch–Whipple Resection or Hemipancreatectomy—Still Standard Treatment for Chronic Pancreatitis?
503
Indications and Rationale for Duodenum?Preserving Pancreatic Head Resection
503
Surgical Technique of DPPHR for Chronic Pancreatitis
504
Early Postoperative Course
504
Long-Term Outcome After DPPHR
506
The Frey Procedure—an Alternative Surgical Approach for all Patients with Chronic Pancreatitis?
507
Summary
508
References
508
Chapter 59 Major Pancreatic Resection
511
Overview
511
Major Pancreatic Resection
511
Pancreatoduodenectomy
513
Distal Pancreatectomy
519
Total Pancreatectomy
520
References
521
Chapter 60 Laparoscopic Surgery
523
Introduction
523
Resection Procedures
523
Drainage Procedures
527
Combination Procedures (Resection and Drainage)
528
Patient Selection
529
Conclusion
530
References
530
Management of Diabetes and Long-Term Outcome of Chronic Pancreatitis
532
Chapter 61 Chronic Pancreatitis: Long-Term Outcome After Medical and Surgical Treatment
532
Introduction
532
Outcomes of Interventional and Surgical Therapy for Pancreatic Pseudocysts
532
Outcome of Pain Management in Chronic Pancreatitis
533
Outcome of Therapeutic Options for Biliary and Pancreatic Ductal Stenoses
535
Conclusion
536
References
536
Chapter 62 Management of Pancreatic Diabetes Secondary to Chronic Pancreatitis
539
Introduction
539
Definition and Prevalence of Pancreatic Diabetes
539
Incidence of Diabetes in Chronic Pancreatitis
539
Risk Factors for Pancreatic Diabetes in Chronic Pancreatitis
540
Pathogenesis of Pancreatic Diabetes
540
Diagnosis of Type 3c Diabetes
541
Clinical Characteristics of Pancreatic Diabetes
541
Complications of Pancreatic Diabetes
542
Therapy of Pancreatic Diabetes
542
Prognosis of Pancreatic Diabetes
544
References
544
Section 5 Autoimmune Pancreatitis
547
Chapter 63 Epidemiology of Autoimmune Pancreatitis
549
Introduction
549
Nationwide Survey of Autoimmune Pancreatitis in Japan
549
First International Survey of Autoimmune Pancreatitis
549
Second International Survey of Autoimmune Pancreatitis
550
Third International Survey of Autoimmune Pancreatitis
550
Conclusions
551
References
552
Chapter 64 Pathogenesis of Autoimmune Pancreatitis
554
Introduction
554
Type 1 Autoimmune Pancreatitis
554
Type 2 Autoimmune Pancreatitis
557
References
558
Chapter 65 Histology of Autoimmune Pancreatitis
560
Introduction
560
Type 1 Autoimmune Pancreatitis
560
Pancreatic Cancer and Autoimmune Pancreatitis
561
Type 2 Autoimmune Pancreatitis
562
Unclassified Autoimmune Pancreatitis
562
Conclusions
562
References
563
Chapter 66 Clinical Manifestation of Type 1 Autoimmune Pancreatitis
564
Type 1 and Type 2 Autoimmune Pancreatitis
564
International Consensus Diagnostic Criteria (ICDC) for Autoimmune Pancreatitis
565
Clinical Features of Type 1 Autoimmune Pancreatitis
565
IgG4-Related Disease (IgG4-RD)
574
References
574
Chapter 67 Clinical Manifestations of Type 2 Autoimmune Pancreatitis
578
Introduction
578
Search Criteria
578
Historical Perspective
578
Terminology
578
Epidemiology
579
Demographics
579
Disease Associations
579
Clinical Symptoms and Signs
579
Diagnosis
580
Differential Diagnosis
580
Treatment
580
Disease Relapse
580
Clinical Course and Outcome
581
Summary
581
References
581
Chapter 68 Laboratory Diagnosis of Autoimmune Pancreatitis
583
Introduction
583
Serum Markers
583
Markers of Autoimmunity
584
Other Markers
585
Conclusion
585
References
586
Chapter 69 What is the Evidence Measuring Immune Markers
588
Introduction
588
Evidence of the Utility of Markers in Autoimmune Pancreatitis Diagnosis
588
Evidence of the Utility of Markers in Differentiating Autoimmune Pancreatitis from Mimicking Conditions
589
Evidence of the Utility of Markers in Predicting Relapse
590
Acknowledgments
591
References
591
Chapter 70 Imaging Diagnosis of Autoimmune Pancreatitis
594
Introduction
594
Pancreatic Parenchyma Imaging
594
Pancreatic Duct Imaging
596
Acknowledgment
597
References
597
Chapter 71 Medical Management of Autoimmune Pancreatitis
599
Introduction
599
Management of Autoimmune Pancreatitis: An Overview
599
Definitions
599
Management of Initial Presentation
600
Management of Relapse
600
Follow-Up and Management of Disease-Related Sequelae
601
Risk of Pancreatic Malignancy
601
Management of Medication Side-Effects
601
Management of Idiopathic Duct-Centric Pancreatitis
602
Conclusion
603
References
603
Long-Term Outcome of Management of Autoimmune Pancreatitis
604
Chapter 72 Long-Term Outcome After Treatment of Autoimmune Pancreatitis
604
Introduction
604
Disease Relapse after Steroids and Treatment
604
Loss of Pancreatic Function and Evolution Toward Chronic Pancreatitis
606
Risk for Pancreatic and Extrapancreatic Cancer
607
References
607
Section 6 Neoplastic Tumors of the Exocrine Tissue: Benign Cystic Neoplasms of the Pancreas
609
Chapter 73 Epidemiology of Cystic Neoplasms of the Pancreas
611
Introduction
611
Pancreatic Cyst Lesions
611
Pancreatic Cystic Neoplasms
613
References
615
Chapter 74 Histologic Classification and Staging of Cystic Neoplasms
617
Introduction
617
Serous Cystic Neoplasms
617
Mucinous Cystic Neoplasm
618
Intraductal Papillary Mucinous Neoplasm
619
Solid Pseudopapillary Neoplasm
621
Acinar Cell Cystadenoma
622
Mature Cystic Teratoma
622
References
622
Chapter 75 Molecular Mechanisms of Cystic Neoplasia
624
Introduction
624
Serous Cystic Neoplasm
624
Intraductal Papillary Mucinous Neoplasm
625
Mucinous Cystic Neoplasm
628
Solid-Pseudopapillary Neoplasm
628
Other Cystic Neoplasms of the Pancreas
628
Clinical Applications
628
Implications for Families
629
Conclusions
629
References
629
Chapter 76 Clinical Presentation of Cystic Neoplasms
633
Introduction
633
Classification
633
General Clinical Presentation of Pancreatic Cysts
633
Clinical Presentation and Characteristics of Serous Cystic Neoplasms
633
Clinical Presentation and Characteristics of Mucinous Cystic Neoplasms
634
Clinical Presentation and Characteristics of Intraductal Papillary Mucous Neoplasms
635
Clinical Presentation and Characteristics of Solid-Pseudopapillary Neoplasms
635
Clinical Presentation and Characteristics of Cystic Pancreatic Neuroendocrine Neoplasms
635
References
635
Chapter 77 Evaluation of Cystic Lesions Using EUS, MRI, and CT
637
Introduction
637
Low-Risk Pancreatic Cysts
637
Pancreatic Cysts with Malignant Potential
640
Future Technology
644
Acknowledgment
645
References
645
Chapter 78 Cytologic Evaluation of Cystic Neoplasms
647
Introduction
647
Cytology of Neoplastic Cysts
647
Summary
651
References
653
Chapter 79 Natural History of Cystic Neoplasms: IPMN, MCN, SCN, and SPN
655
Introduction
655
Intraductal Papillary Mucinous Neoplasms
655
Mucinous Cystic Neoplasms
658
Serous Cystic Neoplasms
658
Solid-Pseudopapillary Neoplasm
659
References
659
Chapter 80 Surveillance or Surgical Treatment in Asymptomatic Cystic Neoplasms
662
Introduction
662
Rationale for Surveillance or Surgery in Asymptomatic Cystic Neoplasms
662
Treatment Guidelines for Asymptomatic Cystic Neoplasms
663
Quality of Life, Surgery Versus Surveillance
663
Cost-Effectiveness of Each Approach
664
References
665
Local and Standard Surgical Treatment of Cystic Neoplasms
666
Chapter 81 Duodenum-Preserving Partial or Total Pancreatic Head Resection
666
Background
666
Classical Pancreatoduodenectomy or Local Extirpation for Cystic Neoplasms of the Pancreatic Head?
666
Rationale for Local Pancreatic Head Resection
667
Duodenum-Preserving Total Pancreatic Head Resection With or Without Segmental Resection of the Peripapillary Duodenum and the Intrapancreatic Common Bile Duct
667
Conclusion
669
Acknowledgment
669
References
670
Chapter 82 Pancreatic Middle Segment Resection
671
Introduction
671
Indications
671
Contraindications
671
Technique
673
Results
674
Conclusions
674
References
674
Chapter 83 The Indications For and Limitations of Tumor Enucleation
676
Introduction
676
Indications
676
Contraindications
677
Surgical Technique
678
Postoperative Management
679
Complications
679
Outcomes
679
Contraindications
681
Cyst Ablation
681
Conclusions
682
References
683
Chapter 84 Standard Surgical Management of IPMN, MCN, SPN, and SCN Lesions: Open Approach
685
Introduction
685
Pancreatic Cystic Neoplasm Subtypes, Surgical Indications, and Operative Intervention
685
Pancreatectomy
687
Conclusion
690
References
690
Chapter 85 Surgical Treatment of Cystic Neoplasms: Laparoscopic Approach
693
Introduction
693
Specific Surgical Considerations and Procedures
693
Future Perspectives
695
References
696
Chapter 86 Management of Recurrence of Cystic Neoplasms
699
Introduction
699
Fate of the Pancreatic Remnant
699
Predictors of Recurrence
700
Low-Risk Lesions Left Behind in Remnant
701
Postoperative Surveillance Strategy
701
Conclusions
702
References
702
Long-Term Outcome of Management of Cystic Neoplasms
704
Chapter 87 Long-Term Outcome After Observation and Surgical Treatment: What is the Evidence?
704
Introduction
704
Serous Cystic Neoplasms
704
Mucinous Cystic Neoplasms
705
Intraductal Papillary Mucinous Neoplasms
705
Solid Pseudopapillary Neoplasms
707
Final Remarks
707
References
707
Section 7 Neoplastic Tumors of Exocrine Tissue: Pancreatic Cancer
709
Chapter 88 Epidemiology of Pancreatic Cancer
711
Incidence, Mortality Trends, Survival Prognosis
711
Cigarette Smoking
711
Diabetes
712
Body Mass Index
712
Alcohol
712
Pancreatitis
713
Dietary Factors
713
Gastrointestinal Microbiome
713
Allergy
713
Family History
714
Conclusions
714
References
714
Chapter 89 Smoking, a Risk for Pancreatic Cancer: Experimental and Clinical Data
717
Introduction
717
Experimental Data Regarding Smoking: A Risk Factor for Pancreatic Cancer
717
Clinical Data Supporting the Experimental Findings
720
Summary
720
References
721
Chapter 90 Molecular Understanding of Development of Ductal Pancreatic Cancer
723
Introduction
723
Genetic Alterations: The Four Mountains
724
Genetic Alterations: The Hills
725
Chromosome Instability
725
Microsatellite Instability
725
Mitochondrial Gene Mutations
726
Expression Changes
726
Precursor Lesions
726
Neoplasms with Acinar Differentiation
727
Clinical Applications
727
Summary and Conclusions
728
References
728
Chapter 91 Familial Pancreatic Cancer
732
Introduction
732
Familial Pancreatic Cancer
732
Pathology of Familial Pancreatic Cancer
732
Common Genetic Variants
734
Summary
734
References
734
Chapter 92 Pathology of Exocrine Pancreatic Tumors
737
Introduction
737
Ductal Adenocarcinoma
737
Cystic Neoplasms
740
Acinar Cell Lesions
743
Conclusions
745
References
745
Chapter 93 Pancreatic Cancer: Precancerous Lesions
749
Introduction
749
Pancreatic Intraepithelial Neoplasia
749
Intraductal Papillary Mucinous Neoplasm
751
Intraductal Tubulopapillary Neoplasm
753
Mucinous Cystic Neoplasms
754
Acknowledgments
755
References
755
Chapter 94 Clinical History and Risk Factors of Pancreatic Cancer
761
Introduction
761
Clinical History of Pancreatic Cancer
761
Risk Factors for Pancreatic Cancer
763
Conclusion
765
References
766
Chapter 95 Pancreatic Cancer Within the Uncinate Process: Radiologic and Clinical Characteristics
768
Embryology of the Pancreas
768
Radiologic Characteristics
768
Clinical Characteristics of the Uncinate Process Pancreatic Cancer (UPDAC)
769
References
771
Chapter 96 The Role of EUS in the Diagnosis and Differential Diagnosis of Neoplastic Lesions
772
Introduction
772
Characteristics of Endoscopic Ultrasound
772
New Screening Modality Comprising Contrast EUS and Elastography
772
EUS-FNA for Solid Pancreatic Lesions (Figs 96.2 and 96.3)
773
Diagnostic Yield and Safety of EUS-FNA for Solid Pancreatic Lesions
773
Factors Affecting EUS-FNA Procedures
775
References
775
Chapter 97 Radiologic Diagnosis of Pancreatic Cancer: CT, MRI
777
Introduction
777
Multidetector Computed Tomography
777
Magnetic Resonance Imaging
782
Conclusion
785
References
787
Chapter 98 Screening of Patients with Hereditary Pancreatic Cancer
789
Pancreatic Cancer Risk and Pancreatic Screening
789
At What Age Should Pancreatic Screening Begin and End?
791
Pancreatic Screening Tests
791
Lesions Identified by Pancreatic Screening
791
Pancreatic Pathology not Detected by Current Screening Tests
792
Surveillance
792
Surgery for Lesions Identified by Pancreatic Screening
793
Developing Better Pancreatic Screening Tests
793
Evaluating the Long-Term Outcomes of Patients who Undergo Pancreatic Screening
794
Summary
794
Acknowledgments
794
References
794
Chapter 99 The Role of ?PET?in Diagnosis of Pancreatic Cancer and Cancer Recurrence
799
Introduction
799
The Role of ?PET?and ?PET-CT?in Primary Tumor Diagnostic of Pancreatic Carcinoma
799
The Role of PET?and PET-CT?in Oncologic Staging of Pancreatic Carcinoma
800
Therapy Control and Diagnostics of Malignant Pancreatic Tumor Recurrence by PET?and PET?CT
801
Potential Value of PET-MRI?in Patients with Pancreatic Cancer
802
Conclusion
803
References
804
Chapter 100 Tumor Markers in Pancreatic Malignancies
806
Conventional Tumor Markers for Pancreatic Cancer
806
Other Markers for Pancreatic Malignancies
807
Novel Markers for Pancreatic Cancer
807
References
808
Chapter 101 The Role of Laparoscopy and Peritoneal Cytology in the Management of Pancreatic Cancer
810
Introduction
810
Laparoscopy
810
Peritoneal Cytology
811
References
812
Chapter 102 Clinical Assessment and Staging of Advanced Pancreatic Cancer
814
Introduction
814
Clinical Presentation
814
Evaluation for Pancreatic Cancer
814
Staging for Advanced Pancreatic Cancer
816
Conclusion
817
References
818
Surgical Treatment of Pancreatic Cancer
820
Chapter 103 Pancreatic Cancer: Indications for Resection
820
Introduction
820
Clinical Criteria for Resection
820
Surgical Criteria for Resection
821
Surgery for Pancreatic Cancer
821
Local Invasion
822
Extrapancreatic Nerve Plexus Invasion
822
Vascular Invasion
822
Lymph Node Metastases
823
Peritoneal Metastases
823
Liver Metastases
824
Other Distant Metastases
824
Effect of Clinical Volume
824
References
824
Chapter 104 Pancreaticoduodenectomy for Pancreatic Cancer, Short- and Long-Term Outcomes After Kausch–Whipple and Pylorus-Preserving Resection
827
Introduction
827
Short-Term Outcome
827
Long-Term Outcome
829
Future Trends
831
References
831
Chapter 105 Left Pancreatectomy for Body and Tail Cancer
834
Introduction
834
Tumor Staging and Resection Eligibility
834
Surgical Technique
834
Minimally Invasive Left Pancreatectomy
836
Postoperative Considerations
837
Conclusions
838
References
838
Chapter 106 Total Pancreatectomy: Indications and Limitations
841
Total Pancreatectomy
841
Elective Total Pancreatectomy and Salvage Completion Pancreatectomy
841
Perioperative Outcomes After Total Pancreatectomy
842
Long-Term Outcomes After Total Pancreatectomy
842
Indications for Total Pancreatectomy
844
Limitations of Total Pancreatectomy
845
References
845
Chapter 107 Laparoscopic and Robotic Resection for Pancreatic Cancer
848
Introduction
848
Patient Selection and Indications for the?MIS?Approach to Pancreaticoduodenectomy
848
Laparoscopic Pancreaticoduodenectomy
848
Robotic Pancreaticoduodenectomy
849
Indications for the MIS?Approach to the Distal Pancreatectomy
852
Laparoscopic Distal Pancreatectomy
852
Robot-Assisted Distal Pancreatectomy
854
Adopting the?MIS?Pancreatectomy: The Learning Curve
855
Conclusion
856
References
856
Chapter 108 Extended Radical Surgery for Pancreatic Cancer
858
Introduction
858
Surgical Procedures and Outcomes
859
Postoperative Outcome of Extended Surgical Approaches
862
References
863
Chapter 109 Palliative Pancreatoduodenectomy: Benefits and Limitations
867
Introduction
867
Definition of Palliative Resection
867
Review of the Literature
867
Management of Preoperatively Under?Staged Patients
869
Conclusions
869
References
870
Chapter 110 Bypass Surgery for Advanced Pancreatic Cancer
872
Introduction
872
Background
872
Symptoms
872
Endoscopic or Interventional Biliary Decompression
873
Surgical Bypass: Techniques
873
Endoscopic Versus Surgical Bypass
873
Gastric Decompression
875
Surgical Technique
875
Comparison of Surgical Gastric Decompression with Nonsurgical Management
875
Our Approach
875
References
876
Nonsurgical Palliation of Pancreatic Cancer
879
Chapter 111 Endoscopic and Interventional Palliation of Pancreatic Cancer
879
Introduction
879
Biliary Obstruction
879
Malignant Gastric Outlet Obstruction
881
Pain Management Derived from Cancer
882
Anticancer Therapy
883
Miscellaneous
883
Acknowledgment
883
References
883
Medical Treatment of Pancreatic Cancer
886
Chapter 112 Neoadjuvant Treatment of Pancreatic Cancer: Downstaging Results
886
Introduction
886
Neoadjuvant Therapy for Resectable Pancreatic Cancer
886
Emerging Recognition of Borderline Resectable Pancreatic Cancer
887
Downstaging Borderline Resectable Disease with Neoadjuvant Therapy
887
Challenges of Neoadjuvant Therapy in Borderline Resectable and Locally Advanced Pancreatic Cancer
888
Future Directions
888
Summary
889
References
889
Chapter 113 Adjuvant Chemotherapy in Pancreatic Cancer
891
Introduction
891
Rationale for Adjuvant Therapy
891
Adjuvant Chemoradiotherapy
895
Future Directions in Adjuvant Therapy
896
Timing and Duration of Adjuvant Therapy
897
Conclusions
897
References
898
Chapter 114 Immunotherapy for Pancreatic Cancer
900
Introduction
900
Immunology of Pancreatic Cancer
900
Therapeutic Vaccines
902
Non-Vaccine Immunomodulators Used in Pancreatic Cancer
904
Targeting Tumor-Associated Macrophages
905
Combination Immunotherapy
905
Conclusion
905
References
905
Chapter 115 Targeted Therapies for Pancreatic Cancer
909
Introduction
909
Genomic Landscape of PDAC
909
Molecular Subtypes Reveal Therapeutic Vulnerabilities
909
Targeting RAS
911
MEK/ERK Inhibition
911
Epidermal Growth Factor Receptor Inhibition
911
Insulin Growth Factor-1 Receptor
912
Pancreatic Stroma
912
Enabling Targeted Therapies in Pancreatic Cancer
912
Summary
913
References
913
Chapter 116 Palliative Chemotherapy for Advanced Pancreatic Cancer: Survival Benefit and Side Effects of Treatment
916
The Clinical Burden of Advanced Pancreatic Cancer
916
The Management of Advanced Pancreatic Carcinoma
916
References
921
Chapter 117 Management of Pain in Pancreatic Cancer
923
Anatomy and Physiology of Pancreas Cancer Pain
923
Pharmacologic Pain Management
923
Chemical Ablation of the Splanchnic Nerves or Celiac Plexus
924
Surgical Options for Treatment of Pancreatic Cancer
926
References
927
Chapter 118 Role of Radio and Proton Beam Therapy for Pancreatic Cancer
930
Introduction
930
Radiation in the Adjuvant Setting
930
Radiation in Borderline Resectable and Locally Advanced Disease
931
Proton Beam Therapy
932
Future Directions
935
References
935
Chapter 119 Management of Cancer Recurrence
939
Introduction
939
Incidence, Timing, and Pattern of Recurrence
939
Surveillance After Resection for Pancreatic Cancer
942
Treatment of Systemic Recurrence of Pancreatic Cancer
945
Treatment of Isolated Local Recurrence of Pancreatic Cancer
945
Rationale for “Local” Therapy Options
945
Chemoradiation for Isolated Local Recurrence
945
Re-resection for Isolated Local Recurrence
0
Selection of Patients for Local Therapy
0
Conclusions
0
References
0
Long-Term Outcome After Treatment of Pancreatic Cancer
950
Chapter 120 Survival and Late Morbidity After Resection of Pancreatic Cancer
950
Introduction
950
Survival after Resection for Pancreatic Cancer
950
Prognostic Risk Factors
953
Long-Term Morbidity
954
Conclusions
957
References
957
Section 8 Neoplastic Tumors of the Endocrine Pancreas: Neuroendocrine Tumors of the Pancreas
963
Chapter 121 Epidemiology and Classification of Neuroendocrine Tumors of the Pancreas
965
Introduction
965
Epidemiology of Pancreatic Neuroendocrine Tumors (Table 121.1)
965
Classification
966
Conclusions
971
Chapter 122 Pathology of Neuroendocrine Neoplasms
974
WHO Classification and TNM Classification
974
Macroscopy
974
Microscopy
975
Cytology
978
Immunohistochemistry and Differential Diagnosis
978
References
980
Chapter 123 Molecular Genetics of Neuroendocrine Tumors
981
Introduction
981
Genetics of Sporadic PanNET
981
Pathways Altered in PanNETs
982
High-Grade Neuroendocrine Carcinomas
985
Comparison of the PanNET Genetic Landscape with Other Pancreatic Neoplasias
985
Familial Syndromes
986
Epigenetics
986
Clinical Implications
987
Conclusions
987
References
988
Chapter 124 Clinical Manifestation of Endocrine Tumors of the Pancreas
991
Introduction
991
Epidemiology of PanNET
991
Clinical Symptoms of PanNET
991
Diagnosis of PanNET
993
References
995
Chapter 125 Evidence of Hormonal, Laboratory, Biochemical, and Instrumental Diagnostics of Neuroendocrine Tumors of the Pancreas
997
Introduction
997
Serum-Based Laboratory Investigations
997
Instrumental and Invasive Investigations
1001
Imaging
1001
Conclusions
1003
References
1003
Chapter 126 Pancreatic Neuroendocrine Tumors in Multiple Neoplasia Syndromes
1005
Introduction
1005
Epidemiology
1005
Genetics
1005
Diagnosis
1006
Clinical Presentation
1007
Surgical Treatment
1007
Medical Treatment
1008
Prognosis
1008
References
1009
Chapter 127 Nonfunctioning Pancreatic Neuroendocrine Tumors: Diagnosis and Management Principles
1011
Definition
1011
Pathology
1011
Mechanism of Tumorigenicity
1011
Clinical Findings
1011
Symptoms
1012
Diagnosis
1012
Surgical Treatment for Localized Lesions
1012
Multidisciplinary Treatment for Metastatic Lesions
1013
References
1015
Chapter 128 Medical and Nucleotide Treatment of Neuroendocrine Tumors of the Pancreas
1016
Introduction
1016
Nonsurgical Treatment of the Secretory Syndromes
1016
Nonsurgical Treatment Directed Against Tumor Growth
1018
Conclusions
1021
References
1021
Chapter 129 Interventional Radiology in the Treatment of Pancreatic Neuroendocrine Tumors
1023
Type of Interventional Radiology Treatment
1023
TAE/TACE
1023
RFA
1024
References
1025
Surgical Management of Endocrine Tumors of the Pancreas
1026
Chapter 130 Surgical Treatment of Endocrine Tumors: Enucleation
1026
Introduction
1026
Observation Versus Surgery for Small Sporadic, Benign?Appearing, Nonfunctioning Pancreatic Neuroendocrine Tumors
1026
Preoperative Imaging and Assessment of Proliferative Tumor Activity
1026
Surgical Technique of Enucleation
1027
Short- and Long-Term Outcomes After Enucleation
1028
Outcome After Laparoscopic Enucleation
1030
References
1030
Chapter 131 Local Treatment of Endocrine Tumors: Duodenum-Preserving Partial or Total Pancreatic Head Resection and Pancreatic Middle-Segment Resection
1033
Background
1033
Surveillance or Treatment of Neuroendocrine Tumors of the Pancreas?
1033
Indication for Surgical Treatment of PanNETs
1034
Parenchyma-Sparing Local Resection of Neuroendocrine Tumors of the Pancreatic Head
1034
Duodenum-Preserving Total or Partial Pancreatic Head Resection
1034
Pancreatic Middle?Segment Resection
1035
Conclusion
1036
Acknowledgment
1036
References
1037
Chapter 132 Surgical Treatment of Endocrine Tumors: Major Oncologic Resection
1038
Introduction
1038
Clinical Workup of Advanced PanNET for Major Oncologic Resection
1038
Surgical Approach to Locally Advanced Nonfunctioning PanNET Without Clinical Evidence of Distant Metastases
1039
Locally Advanced Nonfunctioning PanNET with Clinical Evidence of Distant Metastases
1042
References
1042
Chapter 133 Management of Insulinoma
1046
Introduction
1046
Clinical Features of Insulinomas
1046
Diagnosis of Insulinomas
1046
Localization of Insulinomas
1047
Treatment of Insulinomas
1049
References
1050
Chapter 134 Evidence of Medical and Surgical Treatment of Gastrinoma
1053
Treatment Strategy
1053
Tumor Localization
1053
Surgery
1054
Treatment of Hepatic Metastases
1055
Systemic Chemotherapy
1055
References
1055
Chapter 135 Rare Neuroendocrine Tumors of the Pancreas: Management and Evidence of Surgical Treatment
1057
Introduction
1057
Clinical Features
1057
Prognosis and Survival
1059
Diagnosis
1059
Tumor Localization
1059
Surgical Treatment
1060
Medical Treatment
1060
References
1061
Chapter 136 Treatment of Neuroendocrine Tumors of the Pancreas and Biliary Tract
1063
Introduction
1063
Neuroendocrine Tumors of the Pancreas
1063
Neuroendocrine Tumors of the Duodenum
1066
Neuroendocrine Tumors of the Liver
1068
Neuroendocrine Tumors of the Extrahepatic Biliary Tract
1068
Neuroendocrine Tumors of the Gallbladder
1069
References
1069
Long-Term Outcome After Treatment of Neuroendocrine Tumors of the Pancreas
1073
Chapter 137 Long-Term Outcome After Treatment of Endocrine Tumors
1073
Introduction
1073
Risk Stratification of Pancreatic Endocrine Tumors
1073
Surgical Considerations for Pancreatic Endocrine Tumors
1074
Conclusion
1077
References
1077
Section 9 Periampullary Cancers and Tumors Other Than Pancreatic Cancer
1079
Chapter 138 Periampullary Cancer: Clinical Presentation and Diagnostic Strategies
1081
Introduction
1081
Clinical Presentation
1081
Diagnostic Evaluation
1082
Determination of Extent of Resection
1087
Summary
1088
References
1088
Chapter 139 Histology and Genetics of Cancer of the Papilla, Distal Common Bile Duct, and Duodenum
1091
Carcinoma of Papilla (Ampulla of Vater)
1091
Distal Common Bile Duct Carcinoma
1095
Nonampullary Duodenal Carcinoma
1096
Pathologic Staging of Cancers of this Region
1097
Neuroendocrine Neoplasms and Related Tumors
1097
Pseudotumors that Commonly Mimic Cancer
1097
Secondary Tumors
1098
References
1098
Chapter 140 Adenoma and Adenocarcinoma of the Ampulla of Vater: Diagnosis and Management
1102
Introduction
1102
Epidemiology and Biologic Behavior
1102
Pathology and Pathogenesis
1102
Clinical Features
1103
Diagnosis and Staging of Ampullary Malignancy
1103
Management and Treatment
1105
Posttreatment Surveillance
1107
Long-Term Results of Surgical Resection
1107
References
1107
Chapter 141 Endoscopic Treatment of Adenomas of the Ampulla of Vater: Techniques, Results, Benefits, and Limitations
1112
Introduction
1112
Endoscopic Papillectomy
1112
Preprocedural Evaluation
1112
Techniques
1113
Clinical Results
1115
Complications
1115
Postprocedural Surveillance
1116
Conclusions
1116
References
1116
Chapter 142 Surgical Treatment of Adenoma and Cancer of Papilla of Vater
1118
Introduction
1118
Molecular Pathology of Ampullary Cancer
1118
Endoscopic and Surgical Treatment of Large Adenomas and Carcinoma of the Ampulla of Vater
1119
Ampullectomy for Large Adenomas and Low-Risk Ampullary Cancer
1120
Pancreatoduodenectomy for Advanced Ampullary Cancer
1120
Survival After Ampullectomy and Pancreatoduodenectomy
1121
Conclusion
1121
Acknowledgment
1122
References
1122
Chapter 143 Surgical Treatment of Duodenal Cancer
1125
References
1126
Chapter 144 Surgical Treatment of Distal Cholangiocarcinoma
1127
Introduction
1127
Pyloric Ring Preservation
1127
Lymph Node Dissection
1128
Skeletonization of the Hepatoduodenal Ligament and Dissection of Pancreatic Head Neural Plexus
1130
Bile Duct Cut Margin
1130
Surgery-Related Complications
1131
Summary
1131
References
1131
Chapter 145 Adjuvant and Palliative Chemotherapy of Periampullary Cancers
1133
Introduction
1133
Distal Cholangiocarcinoma
1133
Duodenal Adenocarcinoma
1136
Ampullary Carcinoma
1137
Conclusion
1138
References
1138
Long-Term Survival After Tumor Resection
1141
Chapter 146 Long-Term Survival After Resection of Periampullary Cancer
1141
Introduction
1141
Distal Bile Duct Cancer
1141
Ampullary Region Cancer
1143
Duodenal Cancer
1146
References
1148
Section 10 Transplantation of the Pancreas
1151
Chapter 147 Transplantation of Pancreatic Islets
1153
Introduction
1153
Manufacturing, Release Testing, and Infusion of Allogeneic Human Islets
1153
Selection of Islet Allotransplant Recipients
1153
Outcomes of Islet Allotransplantation in T1D
1156
Adverse Effects of Islet Transplantation and Immunosuppression
1158
Outcomes of Islet Autotransplantation in Chronic Pancreatitis
1159
Research Priorities in Islet Transplantation
1159
Conclusions
1160
Acknowledgments
1160
References
1160
Chapter 148 Transplantation of the Pancreas
1165
Introduction
1165
Epidemiology and Sequelae of Insulin-Dependent Diabetes Mellitus
1165
Historical Aspects
1165
Indications for Pancreas Transplantation
1166
Preoperative Workup and Cardiac Risk Assessment
1167
Donor Selection and Donor Pancreatectomy
1167
Donor Operation
1167
Deceased Cardiac Death Donors (DCD)
1168
Preservation
1168
Technical Aspects of the Recipient Operation
1168
Current Status and Results of Pancreas Transplantation in the United States
1171
Conclusion
1171
References
1171
Index
1173
EULA
1219